Scott M. Wunsch - 30 Jul 2026 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2026, 16:06:31 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch

Key filing fact

Scott M. Wunsch filed Form 4 for Strata Critical Medical, Inc. (SRTA) on 03 Aug 2026.

Key facts

  • This page summarizes Scott M. Wunsch's Form 4 filing for Strata Critical Medical, Inc. (SRTA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002027324 Primary reporting owner

Wunsch Scott M

Relationship
CEO, Logistics
Address
C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
Signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch
Signature date
03 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares
+57,172
Change %
+9.1%
Price
$0.000000*
Shares after
682,746
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1
SRTA transaction

Class A common stock, $0.0001 par value per share

Tax liability

Transaction value
Shares
-13,992
Change %
-2%
Price
$5.09*
Shares after
668,754
Date
31 Jul 2026
Ownership
Direct
Footnotes
F2
SRTA holding

Class A common stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
382,987
Date
30 Jul 2026
Ownership
See Footnotes
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.

Footnote F2

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

Footnote F3

Held directly by a limited liability company of which the Reporting Person is the sole member.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .